Dr. Brandman aims to expand the existing care models for liver transplant patients with alcohol related liver disease and nonalcoholic fatty liver disease, as well as to improve outreach efforts to patients with advanced liver disease.
Dr. Artis and team continue to illuminate the role of ILC2s, a family of white blood cells, with a new discovery published in Nature that has resolved an ongoing controversy.
As reported in Cell, these pain-sensing neurons protect against inflammation in the gut as well as the associated tissue damage, apparently by secreting a molecule called substance P.
The breakthrough research holds promise for developing diagnostic tests for the prediction of cancer progression and therapy.
Building upon his laboratory’s many discoveries centered around ILC3s, Dr. Gregory Sonnenberg has published another breakthrough in Nature (September 7, 2022).
This five-year, $1.25 million grant will enable Dr. Iliev to continue his innovative research into the relationship between certain types of fungi and specific cancers.
This award recognizes exceptional researchers whose scientific excellence and pioneering work have significantly advanced scientific development for the benefit of humanity.
The interdepartmental and interdisciplinary celebration of quality and patient safety initiatives included 27 projects from 13 departments across WCM, Lower Manhattan Hospital, NYP/Queens, and NYP/Brooklyn Methodist.
The WDOM congratulates four of its physician-scientists who have recently been inducted into top-tier medical societies: Dr. Longman and Dr. Schwartz (ASCI); Dr. Fins and Dr. Rafii (AAP).
Dr. Rachel Niec and Dr. Melanie H. Smith have each received an Emerging-Generation Award (2022) from the American Society of Clinical Investigation (ASCI).